Mammalian target of rapamycin signaling and the suprachiasmatic circadian clock
雷帕霉素信号传导和视交叉上生物钟的哺乳动物靶标
基本信息
- 批准号:10409838
- 负责人:
- 金额:$ 35.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-15 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:ActinsAddressAnimalsBehaviorBehavioralBehavioral AssayBiological AssayBiological ClocksBioluminescenceBrainBrain DiseasesCell NucleusCircadian DysregulationClinicalComplexCytoskeletonDataEIF4EBP1 geneEnvironmentEventExhibitsExposure toFDA approvedFRAP1 geneGene ExpressionGeneticGenetic ModelsGenetic TranslationGoalsHypothalamic structureKnowledgeLightMammalsMediatingMental disordersMessenger RNAMetabolismMolecularMusMutant Strains MiceOrganismPathogenesisPatientsPeriodicityPharmaceutical PreparationsPharmacologyPhasePhotoperiodPhysiologicalPhysiologyPropertyProtein BiosynthesisProteinsPublishingRaptorsRegulationRepressionResearchRibosomal Protein S6 KinaseRoleRunningSignal PathwaySignal TransductionSleep DisordersSleep disturbancesSleeplessnessSliceTestingTherapeutic EffectTimeTissuesTranslationsWestern BlottingWorkbasecircadiancircadian pacemakerconditional knockoutenvironmental changeextracellulargenome-wideinhibitorinnovationinterdisciplinary approachloss of functionmTORopathiesmicroscopic imagingmouse geneticsnervous system disordernext generationnovelphotoperiodicitypolymerizationprotein complexrational designresponsesuprachiasmatic nucleus
项目摘要
Project Summary
The objective of the proposed research is to understand physiological functions of the mammalian target of
rapamycin (mTOR) signaling pathway in the brain circadian (~24 h) clock, the hypothalamic suprachiasmatic
nucleus (SCN). To be synchronized with the external and internal environment, gene expression in the SCN
clock is regulated by an intracellular signaling network. A major gap exists in our understanding of the key
signaling events that couple extracellular and intracellular signals to regulate protein synthesis (mRNA
translation). mTOR is a master regulator of mRNA translation. It forms two functionally distinct branches, mTORC
(mTOR complex) 1 and mTORC2. Based on our published work and unpublished preliminary data, our overall
hypothesis is that mTORC1 controls mRNA translation and SCN cell synchrony, whereas mTORC2
controls circadian cytoskeleton reorganization, both of which are critical for the SCN clock function. To
test the hypothesis, activities of specific mTOR components will be manipulated by genetic and pharmacological
approaches. The circadian clock functions will be assessed at the molecular, cellular and animal behavioral
levels using a multidisciplinary approach. Aim 1 will define the functions of the mTORC1 translation effectors
S6Ks in the SCN. We hypothesize that S6Ks regulate the photic clock resetting by regulating mRNA translation.
Aim 2 will assess a role for mTORC1 in mediating photoperiodic regulation of SCN cell synchrony. We
hypothesize that mTORC1 mediates the regulation of SCN synchrony by photoperiods. Aim 3 will identify a role
for mTORC2 in the circadian clock. We hypothesize that mTORC2 regulates SCN properties by controlling
circadian cytoskeleton reorganization. The proposed work is innovative because it utilizes our latest mouse
genetic models to address conceptually novel questions regarding the role of mTOR in the brain clock. The
contributions of the proposed work are expected to be significant, because it will elucidate fundamental
mechanisms whereby mTOR regulates the function of the circadian clock. Aberrant mTOR activities in the brain
are identified in neurological and psychiatric diseases, which are often accompanied by disrupted daily rhythms
in patients. FDA-approved mTOR inhibitors can cause sleep problems. The proposed research will generate
new knowledge that is essential for a mechanistic understanding of the clinical issues regarding mTOR and
clock/sleep disruptions.
项目摘要
这项拟议的研究的目的是了解哺乳动物靶标的生理功能。
雷帕霉素(MTOR)信号通路在大脑昼夜节律(~24小时)时钟、下丘脑视交叉上核中的作用
核(SCN)。要与外部和内部环境同步,基因在SCN中的表达
时钟由细胞内信令网络调节。我们对关键的理解存在着很大的差距
连接细胞外和细胞内信号以调节蛋白质合成(MRNA)的信号事件
译文)。MTOR是信使核糖核酸翻译的主要调节者。它形成了两个功能截然不同的分支,mTORC
(mTOR复合体)1和mTORC2。根据我们已发表的工作和未发表的初步数据,我们的总体
假设mTORC1控制着mRNA的翻译和SCN细胞的同步性,而mTORC2
控制昼夜节律的细胞骨架重组,这两者对SCN时钟功能都是至关重要的。至
检验假设,特定mTOR组分的活动将受到遗传和药理学的控制
接近了。生物钟的功能将从分子、细胞和动物行为方面进行评估
使用多学科方法的水平。目标1将定义mTORC1翻译效应器的功能
SCN中的S6K。我们推测S6K可能通过调节mRNA的翻译来调节光钟的重置。
目的2将评估mTORC1在介导SCN细胞同步性的光周期调节中的作用。我们
假设mTORC1介导了光周期对SCN同步性的调节。目标3将确定一个角色
对于生物钟中的mTORC2。我们假设mTORC2通过控制SCN属性来调节SCN属性
昼夜节律的细胞骨架重组。提议的工作是创新的,因为它利用了我们最新的鼠标
基因模型,以解决有关mTOR在大脑时钟中的作用的概念上的新问题。这个
预计拟议工作的贡献将是巨大的,因为它将阐明根本
MTOR调节生物钟功能的机制。大脑中异常的mTOR活动
在神经和精神疾病中被发现,这些疾病通常伴随着日常节律的中断
在病人身上。FDA批准的mTOR抑制剂会导致睡眠问题。拟议的研究将产生
新知识对于机械地理解有关mTOR和
时钟/睡眠中断。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ruifeng (Ray) Cao其他文献
Ruifeng (Ray) Cao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ruifeng (Ray) Cao', 18)}}的其他基金
Mammalian target of rapamycin signaling and the suprachiamatic circadian clock
雷帕霉素信号传导和视交叉上生物钟的哺乳动物靶标
- 批准号:
10930427 - 财政年份:2023
- 资助金额:
$ 35.6万 - 项目类别:
Integrated stress response and the circadian clock
综合压力反应和生物钟
- 批准号:
10915228 - 财政年份:2022
- 资助金额:
$ 35.6万 - 项目类别:
Mammalian target of rapamycin signaling and the suprachiasmatic circadian clock
雷帕霉素信号传导和视交叉上生物钟的哺乳动物靶标
- 批准号:
10030731 - 财政年份:2020
- 资助金额:
$ 35.6万 - 项目类别:
Mammalian target of rapamycin signaling and the suprachiasmatic circadian clock
雷帕霉素信号传导和视交叉上生物钟的哺乳动物靶标
- 批准号:
10256791 - 财政年份:2020
- 资助金额:
$ 35.6万 - 项目类别:
Mammalian target of rapamycin signaling and the suprachiasmatic circadian clock
雷帕霉素信号传导和视交叉上生物钟的哺乳动物靶标
- 批准号:
10655581 - 财政年份:2020
- 资助金额:
$ 35.6万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 35.6万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 35.6万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 35.6万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 35.6万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 35.6万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 35.6万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 35.6万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 35.6万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 35.6万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 35.6万 - 项目类别:
Research Grant